We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

COPAN DIAGNOSTICS

COPAN (which stands for COllection and Preservation for ANalysis) is a global market leader in sample collection and ... read more Featured Products: More products

Download Mobile App





Copan Showcases Fully Automated Solutions for Antibiotic Susceptibility Testing at ECCMID 2022

By LabMedica International staff writers
Posted on 25 Apr 2022

COPAN Diagnostics (Murrieta, CA, USA) showcased its range of fully automated solutions for identification and antimicrobial susceptibility testing (AST) in clinical microbiology at the 32nd European Congress of Clinical Microbiology & Infectious Diseases (ECCMID 2022). More...

COPAN demonstrated the FDA-cleared Colibri, a fully automated specimen workup instrument designed to prepare MALDI-TOF ID targets and create bacterial suspensions for AST. Colibri is an in vitro diagnostic device for use with the bioMérieux VITEK MS or Bruker MALDI Biotyper CA mass spectrometry systems. It automatically picks isolated colonies for further workup and investigations. Colibri can also seed colonies into various size tubes or bottles to prepare McFarland suspensions for AST, verifying opacity of suspensions using the onboard nephelometer. The system applies barcode labels to tubes and prepares purity check plates from these suspensions.

Colibri is paired with COPAN’s artificial intelligence (AI) software, PhenoMATRIX, to offer clinical microbiology laboratories cutting-edge, intelligence driven solutions for specimen workup to help streamline workflow and address the most challenging demands in the laboratory. PhenoMATRIX TAG colony selection software automatically chooses isolated colonies on plated media for picking. By grouping negative cultures, which represent the majority of cultures screened, Microbiologists can quickly review up to 40 plates at a time and batch release negative results quickly. Eliminating the need to review each plate manually, saves precious time and allows technicians to focus on complex cultures which require their unique expertise, and to consult with physicians to provide better patient care.

COPAN also exhibited its UniVerse fully automated instrument for molecular specimen preparation. UniVerse revolutionizes up front sample processing for molecular diagnostics automatically managing accessioning, labeling, vortexing, and aliquoting into assay tubes and 96-well plates. UniVerse is fully LIS interfaced, it increases laboratory throughput with complete traceability, reliability and accuracy. It increases productivity while decreasing operational cost and allows valuable human resources to be re-deployed to higher level tasks.

Related Links:
COPAN Diagnostics 


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Aspiration System
VACUSAFE
New
Fully Automated Urinalysis System
DxU 1800 Fully Automated Urinalysis System
New
Nucleic Acid Purification Instrument
QIAsymphony Connect
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The AidaBREAST assay integrates multimodal data to provide patient-specific 10-year recurrence risk and individualized predictions of radiation therapy benefit (photo courtesy of PreludeDx)

Validated Test Predicts Recurrence Risk and Radiation Benefit in Early-Stage Breast Cancer

For women with early-stage invasive breast cancer who undergo breast-conserving surgery, clinicians must assess both the risk of locoregional recurrence and the potential benefit of adjuvant radiation therapy.... Read more

Microbiology

view channel
Image: Invasive aspergillosis (IA) is a potentially life-threatening infection caused by Aspergillus mold that primarily affects people with severely weakened immune systems. (Image Credit: Adobe Stock)

Rapid Urine Test Aids Diagnosis of Invasive Aspergillosis

Invasive aspergillosis is an uncommon mold infection in the general population but can pose serious risks for people with weakened immune defenses. Diagnosis can be difficult because existing approaches... Read more

Technology

view channel
Image: The laser-based photoacoustic spectroscopy setup consists of a Mid-IR laser equipped with three QCL modules covering wavelengths from 5.6 μm to 12.9 μm, two silver coated mirrors (SCM), a dichroic mirror (DM) with a transmittance of 90%, a thermal power sensor head (PM) to monitor the output laser power, a mechanical chopper (MC) for frequency modulation and a CEPAS-detector with a self-designed swab holder (SH). (Credit: Graunke, T., Scholz, T., Pieniak, M. et al. Scientific Reports (2026). https://doi.org/10.1038/s41598-026-68298-9)

Laser-Based Swab Analysis Shows Promise for Detecting Disease-Linked Odor Patterns

Disease-related changes in volatile organic compounds can alter body odor, producing measurable patterns in exhaled breath and bodily fluids. Current analytical methods can be complex, time-consuming,... Read more

Industry

view channel
Image: Natera\'s MCED assay analyzes cell-free DNA in blood to screen for multiple cancers (Image Credit: Adobe Stock)

Multi-Cancer Screening Blood Test Gains FDA Breakthrough Designation

Natera Inc.’s (Austin, TX, USA) multi-cancer early detection (MCED) assay has received Breakthrough Device designation (BDD) from the U.S. Food and Drug Administration (FDA). The assay analyzes cell-free... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.